bluuebunny/crossref_metadata_2025_split huggingface dataset:
“It’s okay because I’m just driving”: an exploration of self-reported mobile phone use among Mexican drivers
Authors: Useche Sergio A. , Alonso Francisco , Faus Mireia , Cervantes Trejo Arturo , Castaneda Isaac , Oviedo-Trespalacios Oscar 
Published: February 2024

Introduction
Technological advancements have the potential to enhance people’s quality of life, but their misuse can have a detrimental impact on safety. A notable example is the escalating issue of distracted driving resulting from the use of mobile phones behind the wheel, leading to severe crashes and injuries. Despite these concerns, both drivers’ usage patterns and their risk-related associations remain scarcely documented in Mexico. Therefore, this descriptive study aimed to examine the mobile phone usage of Mexican drivers, its relationships to risk awareness and near-miss/crash involvement, and the self-reported underlying reasons for this behavior.

Methods
This cross-sectional study utilized a sample of 1,353 licensed Mexican drivers who took part in a nationwide series of interviews regarding their onboard phone use settings.

Results
A significant percentage of drivers (96.8%) recognize using a mobile phone while driving as high-risk behavior. However, only 7.4% reported completely avoiding its use while driving, with 22.4% identified as high-frequency users. Frequency was also found positively associated with the self-reported rate of near-misses and crashes. Furthermore, qualitative data analysis highlights the emergence of a ‘sense of urgency’ to attend to phone-related tasks in response to daily demands and life dynamics, offering a potential explanation for this behavior.

Conclusion
The results of this study suggest common patterns of onboard mobile use among Mexican drivers concerning driving situations and associated risks. This underscores the need for increased efforts to discourage onboard phone use in the country.
Pharmacist-social worker interprofessional relations and education in mental health: a scoping review
Authors: Boylan Paul , Knisley Jamie , Wiskur Brandt , Nguyen Jessica , Lam Kristine , Hong Jisoo , Caballero Joshua 
Published: February 2024

Background
One in eight patients is affected by a mental health condition, and interprofessional mental health teams collaborate to improve patient care. While pharmacists and social workers are recognized as mental health team members, there is a lack of literature describing interprofessional relations and education between these professions, especially as it pertains to mental health. The purpose of this review was to identify and characterize reports describing pharmacist-social worker interprofessional relations and education within mental health.

Methodology
To address this knowledge gap, this scoping review was conducted to collect and characterize reports published between January 1, 1960 and August 18, 2023 describing pharmacist-social worker interprofessional relations and education within the field of mental health. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines were followed. Ovid MEDLINE, CINAHL, and Social Work Abstracts were searched using keywords “pharmacy student,” “pharmacist,” “social work student,” “social worker,” and “social work.” Reports were included if they were published in English and interprofessional relations or education occurred directly between (student) pharmacists and social workers.

Results
Three hundred twenty records were identified and three records were included: one cross sectional study, one qualitative educational project, and one case report. Each record suggested positive patient and/or educational outcomes developing from pharmacist-social worker interprofessional relations and education. In clinical practice, pharmacist-social work teams identified mental health risk factors, reduced 30-day readmissions, and improved post-discharge telehealth care. In the classroom, a social worker improved pharmacy students’ confidence assessing patient suicidal ideations.

Conclusions
This scoping review identified needs and areas for future research: pharmacist interprofessional education with Master of Social Work and Doctor of Social Work degree students, transitional care and mental health outcome measure reporting using evidence-based outcomes, and development of scholarly teaching projects utilizing higher-level educational frameworks beyond learner reactions.
COVID-19, influenza H1N1 e dengue: aspectos epidemiológicos e profiláticos no município de Palmas – TO
Authors: Ignácio Gagossian Débora , Barbosa de Brito Ana Paula , Silva Conceição Dannicia , Fonseca Moreira da Silva Juliana , Barbosa Baptista Anderson 
Published: February 2024

Introdução: A COVID-19, a gripe H1N1 e a dengue são doenças que, cada uma na sua intensidade e modo, trazem grandes desafios e preocupações para a saúde nacional. Objetivo: verificar a prevalência da COVID, H1N1 em Palmas-TO. Metodologia Foi realizado um estudo descritivo com dados primários e secundários, utilizando-se como unidade de análise o Município de Palmas, capital do estado do Tocantins, com base nos registros da COVID-19, da gripe H1N1 e da dengue. Utilização de dados referentes ao período de 2021 a 2022. Resultados e discussão: em janeiro de 2021, a vacinação contra a COVID-19 foi iniciada em Palmas-TO. Comparando o número de mortes por COVID-19 em Palmas-TO entre as semanas epidemiológicas 1 a 30 nos anos de 2020, 2021 e 2022, fica clara a redução de mortes no ano de 2022 em relação ao de 2021. Ao comparar os casos de dengue e de COVID-19 até a semana epidemiológica 30 do ano de 2022, percebe-se que o pico de casos de dengue ocorreu na 1ª semana epidemiológica com 749 casos e que o pico de casos de COVID-19 ocorreu na 5ª semana epidemiológica com 4211 casos. No período entre 01/06/2021 e 12/07/2022 não foram registrados casos detectáveis de Influenza H1N1 em Palmas, Tocantins. Conclusão: Sobre a correlação da COVID-19 com a dengue, percebeu-se que a pandemia pode ter influenciado negativamente no rastreamento dessa arbovirose.
Modeling low‐temperature–induced failure of pressurized pipelines
Authors: Mahgerefteh Haroun , Atti Olufemi 
Published: October 2005

AbstractThe development of a rigorous mathematical model for simulating the processes leading to the transition of an initially stable through‐wall defect into an elongated running fracture in pressurized pipelines is described. The application of the model to the puncture of a gas pipeline followed by its isolation indicates significant and rapid localized cooling of the pipe wall to temperatures well below its ductile to brittle transition temperature. The resulting order of magnitude drop in the fracture toughness coupled with the pressure stresses at the defect plane are shown to lead to catastrophic pipeline failure in the form of a running fracture some 2000 s after its puncture. Significantly, delay in pipeline isolation after its puncture is shown to have a profound effect in circumventing such failures. The above study for the first time quantitatively highlights the importance of taking into account the expansion‐induced cooling effects as a credible failure scenario when undertaking safety assessment of pressurized pipelines. © 2005 American Institute of Chemical Engineers AIChE J, 2006
Synthesis and characterization of phosphorescent cyclometalated iridium complexes containing 2,5‐diphenylpyridine based ligands
Authors: Xu MaoLiang , Li WenLian , An ZhongWei , Zhou Qun , Wang GeYang 
Published: October 2005

AbstractA series of phosphorescent cyclometalated iridium complexes with 2,5‐diphenylpyridine‐based ligands has been synthesized and characterized to investigate the effect of the simple ligand modification on photophysics, thermostability and electrochemistry. The complexes have the general structure (C∧N)2Ir(acac), where C∧N is a monoanionic cyclometalating ligand [e.g. 2,5‐diphenylpyridyl (dppy), 2,5‐di(4‐methoxyphenyl)pyridyl (dmoppy), 2,5‐di(4‐ethoxyphenyl)pyridyl (deoppy) and 2,5‐di(4‐ethylphenyl)pyridyl (deppy)]. The absorption, emission, cyclic voltammetry and thermostability of the complexes were systematically investigated. The (dppy)2Ir(acac) has been characterized using X‐ray crystallography. Calculation on the electronic ground state of (dppy)2Ir(acac) was carried out using B3LYP density functional theory. The highest occupied molecular orbital (HOMO) level is a mixture of Ir and ligand orbitals, while the lowest occupied molecular orbital (LUMO) is predominantly dppy ligand‐based. Electrochemical studies showed the oxidation potentials of (dmoppy)2Ir(acac), (deoppy)2Ir(acac), (deppy)2Ir(acac) were smaller than that of (ppy)2Ir(acac), while the oxidation potential of (dppy)2Ir(acac) was larger relative to (ppy)2Ir(acac). The 10% weight reduction temperatures of these complexes were above that of (ppy)2Ir(acac). All complexes exhibited intense green photoluminescence, which has been attributed to MLCT triplet emission. The maximum emission wavelengths in CH2Cl2 at room temperature were in the range 531–544 nm, which is more red‐shifted than that of (ppy)2Ir(acac). Copyright © 2005 John Wiley & Sons, Ltd.
Preparation, characterization, thermooxidative degradation, and stability of polyaniline/polyacrylonitrile composites in terms of direct‐current electrical conductivity retention
Authors: Al‐Ahmed Amir , Mohammad Faiz , Rahman M. Zaki A. 
Published: October 2005

AbstractElectrically conducting composites based on polyaniline and polyacrylonitrile were prepared by two slightly different techniques and were characterized by Fourier transform infrared spectroscopy and scanning electron microscopy. The thermooxidative degradation of the composites was studied by simultaneous thermogravimetric analysis and differential thermal analysis techniques. The stability of the composites in terms of direct‐current electrical conductivity retention was studied in an oxidative environment by isothermal and cyclic techniques. The composites were thermally stable under ambient environmental conditions; however, their properties were dependent on the method of preparation. © 2005 Wiley Periodicals, Inc. J Appl Polym Sci 99: 437–448, 2006
Carbon black‐filled immiscible polypropylene/epoxy blends
Authors: Li Ying , Wang Shifeng , Zhang Yong , Zhang Yinxi 
Published: October 2005

AbstractCarbon black‐ (CB) filled immiscible thermoplastic/thermosetting polymer blends consisting of polypropylene (PP) and epoxy resin were reported in this paper. The PP/epoxy/CB blends with varied compositions and different processing sequences were prepared by melt‐mixing method. The CB distribution and the relationship between morphology and electrical properties of the PP/epoxy/CB blends were investigated. Scanning electron microscopy (SEM), optical microscopy, and extraction experimental results showed that in PP/epoxy blends CB particles preferentially localized in the epoxy phase, indicating that CB has a good affinity with epoxy resin. The incorporation of CB changed the spherical particles of the dispersed epoxy phase into elongated structure. With increasing epoxy content, the elongation deformation of epoxy phase became more obvious and eventually the blends developed into cocontinuous structure. When CB was initially blended with PP and followed by the addition of epoxy resin, the partial migration of CB from PP to the epoxy phase was observed. When the PP/epoxy ratio was 40/60, the percolation threshold was reduced to about 4 phr CB, which is half of the percolation threshold of the PP/CB composite. © 2005 Wiley Periodicals, Inc. J Appl Polym Sci 99: 461–471, 2006
Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: Correlating magnetic resonance imaging findings with disease severity
Authors: Loeuille Damien , Chary‐Valckenaere Isabelle , Champigneulle Jacqueline , Rat Anne‐Christine , Toussaint Frédéric , Pinzano‐Watrin Astrid , Goebel Jean Christophe , Mainard Didier , Blum Alain , Pourel Jacques , Netter Patrick , Gillet Pierre 
Published: October 2005

AbstractObjectiveTo determine the magnetic resonance imaging (MRI), macroscopic, and microscopic characteristics of synovial membrane inflammation, to study the relationship between disease severity and the degree of synovial inflammation on MRI and on macroscopic and microscopic examination, and to look for colocalization of chondral lesions and synovial inflammation.MethodsThirty‐nine patients with knee osteoarthritis (OA) were classified into 2 groups according to the severity of cartilage lesions as revealed by chondroscopy. Group 1 (n = 14) had mild cartilage lesion(s) without exposure of subchondral bone. Group 2 (n = 25) had severe cartilage lesion(s) with focal or diffuse exposure of subchondral bone. Synovitis was evaluated on T1‐weighted MRI sequences according to the degree of synovial thickening on a 4‐point scale (ranging from 0 to 3) in 5 regions of interest. Synovial membrane was macroscopically scored, and biopsies were performed on the 5 preselected sites for histologic scoring.ResultsThe mean ± SD synovial thickening score on MRI was 1.55 ± 0.90, with no significant difference between groups 1 and 2. Intra‐ and interobserver reproducibility of the total synovial score was excellent, and interobserver reproducibility of the MRI grade was good. Synovitis was diffuse and associated with chondral lesions only in the medial femorotibial compartment (r = 0.49, P = 0.001). The degree of synovial thickening on MRI correlated with qualitative macroscopic analysis (rs = 0.58, P < 0.001) and with microscopic features (synovial lining cells [rs = 0.23, P < 0.007], surface fibrin deposition [rs = 0.12, P < 0.01], fibrosis [rs = 0.31, P < 0.006], edema [rs = 0.17, P = 0.07], congestion [rs = 0.30, P < 0.005], and infiltration [rs = 0.46, P < 0.0001]). Fibrin and infiltration parameters were more severe in end‐stage disease (P = 0.009 and P = 0.02, respectively).ConclusionSynovitis may be present from the onset of OA and may be evaluated on MRI. MRI evaluation of synovitis could be used to classify OA patients in clinical trials and could help to identify those who could benefit from synovium‐targeted therapy.
The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids
Authors: Ramanan A. V. , Campbell‐Webster N. , Ota S. , Parker S. , Tran D. , Tyrrell P. N. , Cameron B. , Spiegel L. , Schneider R. , Laxer R. M. , Silverman E. D. , Feldman B. M. 
Published: October 2005

AbstractObjectiveChildhood dermatomyositis (DM) is often a chronic disease, lasting many years. It has traditionally been treated with long‐term corticosteroid therapy; side effects are often seen. For more than a decade, methotrexate (MTX) has been safely used for the treatment of juvenile arthritis. Here, we report use of MTX as first‐line therapy for DM, along with aggressively tapered corticosteroids, in an attempt to reduce treatment‐related side effects.MethodsWe studied an inception cohort of 31 children with DM who were rigorously followed up in our myositis clinic, and compared them with a control group of 22 patients with incident cases of juvenile DM who received treatment just before we instituted a policy of first‐line therapy with MTX. The mean starting dosage of MTX in the study group was 15 mg/m2/week.ResultsBoth groups had similar improvement in strength and physical function; however, the median time during which patients in the study group received corticosteroids was 10 months, compared with 27 months for controls (P < 0.0001). As a result, the cumulative prednisone dose in the study group was approximately half that in the control group (7,574 mg versus 15,152 mg; P = 0.0006). The study group had greater height velocity during the first year of treatment and a smaller increase in the body mass index over the first 2 years. In the control group, the relative risk of cataracts developing was 1.95 (95% confidence interval 1.05–4.17). Side effects of MTX were rarely observed.ConclusionUse of MTX in conjunction with an aggressively tapered course of prednisone may be as effective as traditional long‐term corticosteroid therapy for children with DM, while decreasing the cumulative dose of corticosteroids.
Pseudodominant inheritance of the hyperimmunoglobulinemia D with periodic fever syndrome in a mother and her two monozygotic twins
Authors: Hospach Toni , Lohse Pia , Heilbronner Helmut , Dannecker Guenther E. , Lohse Peter 
Published: October 2005

AbstractHyperimmunoglobulinemia D with periodic fever syndrome (HIDS) is a recessively inherited recurrent fever syndrome. We describe a family of 2 monozygotic twins and their mother with characteristic symptoms of HIDS, but normal levels of IgD and IgA, and with a dominant inheritance pattern. Mevalonate kinase (MK) activity was deficient in both children, and analysis of the MVK gene revealed compound heterozygosity for 2 new mutations, G25G and R277H. Being positioned adjacent to a donor splice site, the G25G mutation was shown by reverse transcription–polymerase chain reaction analyses to cause aberrant splicing of the MVK messenger RNA, thus being disease‐relevant. The mother, who was also symptomatic during her childhood and adolescence, was a compound heterozygote for I268T and R277H. Our findings expand the genetic and ethnic spectrum of HIDS and show that the possible presence of this disease cannot be excluded based solely on inheritance patterns. In each case in which HIDS is clinically suspected, analysis of MK activity and/or the MVK gene (especially exons 9 and 11) should be performed.
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteins
Authors: Huizinga Tom W. J. , Amos Christopher I. , van der Helm‐van Mil Annette H. M. , Chen Wei , van Gaalen Floris A. , Jawaheer Damini , Schreuder Geziena M. T. , Wener Mark , Breedveld Ferdinand C. , Ahmad Naila , Lum Raymond F. , de Vries Rene R. P. , Gregersen Peter K. , Toes Rene E. M. , Criswell Lindsey A. 
Published: October 2005

AbstractObjectiveThe main genetic risk factor for rheumatoid arthritis (RA), the HLA region, has been known for 25 years. Previous research has demonstrated, within the RA population, an association between HLA–DRB1 alleles carrying the shared epitope (SE) and antibodies directed against cyclic citrullinated peptides (anti‐CCP antibodies). We undertook this study to make the first comparison of SE allele frequencies in the healthy population with those in RA patients who do or do not harbor anti‐CCP antibodies.MethodsHLA–DRB1 typing was performed in 408 RA patients from the Leiden Early Arthritis Clinic (the Leiden EAC; a Dutch population‐based inception cohort in which disease course was followed up over time), in 423 healthy Dutch controls, and in 720 affected members of 341 US multiplex (sibpair) families of Caucasian origin from the North American RA Consortium (NARAC) with well‐established disease and fulfilling the American College of Rheumatology classification criteria for RA. The presence of anti‐CCP antibodies was determined by enzyme‐linked immunosorbent assay.ResultsFor the Leiden EAC, the odds ratio (OR) describing the association of 2 copies of the SE allele with anti‐CCP positivity (using no copies of the SE allele in the healthy control group as the referent) was 11.79 (P < 0.0001), while the OR for 1 SE allele was 4.37 (P < 0.0001). No association with the SE was observed in the Dutch anti‐CCP–negative RA patients. For the NARAC families, linkage and association analysis revealed the SE to be associated only with anti‐CCP–positive disease and not with anti‐CCP–negative disease. Stratified analyses indicated that anti‐CCP antibodies primarily mediated association of the SE with joint damage or disease persistence.ConclusionHLA–DRB1 alleles encoding the SE are specific for disease characterized by antibodies to citrullinated peptides, indicating that these alleles do not associate with RA as such, but rather with a particular phenotype.
Patterns of clinical remission in select categories of juvenile idiopathic arthritis
Authors: Wallace Carol A. , Huang Bin , Bandeira Marcia , Ravelli Angelo , Giannini Edward H. 
Published: October 2005

AbstractObjectiveTo characterize disease activity patterns in a large cohort of children with juvenile idiopathic arthritis (JIA), by applying newly developed preliminary definitions of inactive disease, clinical remission on medication, and clinical remission off medication.MethodsChildren with persistent or extended oligoarthritis, polyarthritis (either rheumatoid factor [RF] positive or RF negative), or systemic JIA who had been followed up for a period of at least 4 years were evaluated for episodes of inactive disease, clinical remission on medication, and clinical remission off medication. Descriptive statistics, correlation analyses, and survival analyses were performed.ResultsFour hundred thirty‐seven children met the criteria for review. Three hundred ninety‐one patients (89%) experienced a total of 878 episodes of inactive disease, with a median episode length of 12.7 months. Two hundred twenty‐eight episodes of inactive disease (26%) resulted in clinical remission off medication; it was equally as likely that episodes of inactive disease would or would not follow a period of clinical remission on medication. Thirty‐six percent of episodes of clinical remission off medication persisted for at least 2 years, and only 6% of such episodes persisted for 5 years. RF‐positive patients were the least likely to achieve clinical remission off medication (5%), and patients with persistent oligoarticular JIA were the most likely (68%). Among patients with persistent oligoarticular JIA, most of the disease course was characterized by inactive disease; in most other patients the majority of the disease course involved active disease.ConclusionUsing newly developed preliminary criteria for inactive disease, clinical remission on medication, and clinical remission off medication, we observed that only one‐fourth of 878 episodes of inactive disease resulted in clinical remission off medication during followup of at least 4 years. Only a small proportion of episodes of clinical remission off medication were sustained for >5 years. These results highlight the critical need for therapies that have the ability to induce sustained remission of JIA.